1. Coronavirus Vaccine: NYU's Dr. Robyn Gershon talks COVID-19 vaccine concerns  Yahoo Finance
  2. In Global Covid-19 Vaccine Race, Chinese Shot Receives First Foreign Approval  The Wall Street Journal
  3. AstraZeneca resumes COVID-19 vaccine trials in South Africa, health dept says  Reuters
  4. COVID-19: UAE vaccine strengthens fight against coronavirus | Editorials  Gulf News
  5. Pharma Insiders Are Raking in Money Despite No Guaranteed COVID-19 Vaccine | Opinion  msnNOW
  6. View Full coverage on Google News
AstraZeneca has resumed COVID-19 vaccine trials in South Africa, more than a week after tests were paused due to serious side effects in a participant in Britain, an official at the country's Department of Health told Reuters on Tuesday.AstraZeneca has resumed COVID-19 vaccine trials in South Africa, more than a week after tests were paused due to serious side effects in a participant in Britain, an official at the country's Department of Health told Reuters on Tuesday.

AstraZeneca resumes COVID-19 vaccine trials in South Africa, health department says | Reuters

Some volunteers withdrew from J&J vaccine trial in Spain after serious side effect reported in AstraZeneca UK volunteer.Some volunteers withdrew from J&J vaccine trial in Spain after serious side effect reported in AstraZeneca UK volunteer.

After AstraZeneca, some quit J&J COVID-19 trial in Spain | News | Al Jazeera

The United Arab Emirates has become the first country outside China to approve emergency usage of a Chinese Covid-19 vaccine candidate, in a vote of confidence for a state-backed drugmaker racing global rivals to stop the spread of the coronavirus.The United Arab Emirates has become the first country outside China to approve emergency usage of a Chinese Covid-19 vaccine candidate, in a vote of confidence for a state-backed drugmaker racing global rivals to stop the spread of the coronavirus.

In Global Covid-19 Vaccine Race, Chinese Shot Receives First Foreign Approval - WSJ

Sarah Gilbert, professor of vaccinology at Oxford University, said no corners were being cut when it came to ensuring that a vaccine was safe.Sarah Gilbert, professor of vaccinology at Oxford University, said no corners were being cut when it came to ensuring that a vaccine was safe.

Top Oxford professor behind Covid-19 vaccine reiterates safety is 'top of the list' | Daily Mail Online

Through aggressive promotion and selective media leaks to inflate their stock prices, pharmaceutical company executives and insiders are profiteering from the pandemic. Congress must stop them.

Pharma Insiders Are Raking in Money Despite No Guaranteed COVID-19 Vaccine | Opinion

Gulf News Zero Campaign aims to raise awareness to help the country flatten the curveGulf News Zero Campaign aims to raise awareness to help the country flatten the curve

COVID-19: UAE vaccine strengthens fight against coronavirus | Editorials – Gulf News

Recon: AstraZeneca resumes COVID vaccine trials in South Africa, Brazil, US study still on hold | RAPS

“The complications are described in the instructions and are predictable,” Russia's health minister said.“The complications are described in the instructions and are predictable,” Russia's health minister said.

1 in 7 Russian Coronavirus Vaccine Volunteers Report Side Effects - The Moscow Times

The United Arab Emirates (UAE) on Monday granted emergency approval for use of a coronavirus vaccine developed in China, six weeks after human trials on the vaccine started in the country.

UAE approves urgent use of China-developed COVID-19 vaccine after test on 31,000 volunteers - Global Times

Trials of AstraZeneca Covid-19 vaccine remain on hold until midweekTrials of AstraZeneca Covid-19 vaccine remain on hold until midweek

Coronavirus: Global infections approach 30 million

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Times of India brings the Latest & Top Breaking News on Politics and Current Affairs in India & around the World, Cricket, Sports, Business, Bollywood News and Entertainment, Science, Technology, Health & Fitness news & opinions from leading columnists.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

Investors got a not-so-sweet reminder of the difficulties and risks of clinical trials.Investors got a not-so-sweet reminder of the difficulties and risks of clinical trials.

AstraZeneca Shows the Risk of Investing in Coronavirus Vaccine Stocks | The Motley Fool

Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.

There Won’t Be Enough COVID Vaccines for Everybody Until 2024, Warn Vaccine Makers

Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.

There Won't Be Enough COVID Vaccines for Everybody Until 2024, Warn Vaccine Makers

Germany boosts own vaccine makers in race for COVID-19 jabGermany boosts own vaccine makers in race for COVID-19 jab

Germany boosts own vaccine makers in race for COVID-19 jab | Taiwan News

The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.

Researchers trial inhaled versions of Oxford and Imperial Covid-19 vaccine candidates - world news - Hindustan Times

50 countries have already expressed interest in purchasing the Sputnik V vaccine, developed by Russia’s Gamaleya Research Institute. The Russian Direct Investment Fund...50 countries have already expressed interest in purchasing the Sputnik V vaccine, developed by Russia’s Gamaleya Research Institute. The Russian Direct Investment Fund...

Russian Direct Investment Fund CEO Stresses Tech Based on Monkey Adenoviral Vectors 'Yet Unproven' - Sputnik International

Experts call the global response to the COVID-19 pandemic a "collective failure."Experts call the global response to the COVID-19 pandemic a "collective failure."

Pandemic total passes 29 million as cases hit daily high | CIDRAP

Coronavirus (Covid-19) Cases & deaths, Vaccine Latest News Update:Global Coronavirus Updates: Globally, at least 926,716 people have died after testing positive and 19.82 lakh people have recovered as well.

Global Coronavirus Latest Update, Sept 15: Covid-19 cases & deaths | Covid-19 Vaccine Latest News | Coronavirus Today News Update

About one in seven volunteers who received a groundbreaking Russian coronavirus vaccine have complained of side effects such as muscle pain, weakness, and fever, according to the country's Minister for Health Mikhail Murashko.About one in seven volunteers who received a groundbreaking Russian coronavirus vaccine have complained of side effects such as muscle pain, weakness, and fever, according to the country's Minister for Health Mikhail Murashko.

14% of volunteers testing pioneering Russian Covid-19 vaccine ‘Sputnik V’ have experienced side effects, health ministry says — RT Russia & Former Soviet Union

A group of scientists sent a formal letter to the Lancet on Monday outlining doubts about the accuracy of early data on Russia's COVID-19 vaccine, one of the authors said, adding further fuel to a dispute surrounding the "Sputnik-V" shot.A group of scientists sent a formal letter to the Lancet on Monday outlining doubts about the accuracy of early data on Russia's COVID-19 vaccine, one of the authors said, adding further fuel to a dispute surrounding the "Sputnik-V" shot.

Fifteen scientists launch critique of Russia’s COVID-19 vaccine data – EURACTIV.com

Two scientists break down what we know about the potential Covid-19 vaccine side effects, what we might expect, and how to deal with uncertainty.Two scientists break down what we know about the potential Covid-19 vaccine side effects, what we might expect, and how to deal with uncertainty.

Coronavirus vaccine side effects: 1,000 readers asked, scientists answered

UK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been releasedUK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been released

Coronavirus Vaccine U.K. Trial Restarts, But Scientists Question Lack of Transparency - Scientific American

The director of the Chinese CDC, Gao Fu, reportedly said that not everyone in the country will need to get vaccinated against COVID-19.The director of the Chinese CDC, Gao Fu, reportedly said that not everyone in the country will need to get vaccinated against COVID-19.

COVID-19: China prioritises frontline workers, says no need to vaccinate entire population - Republic World

The biggest drugmakers in the hunt for a COVID-19 vaccine have been racing to lock up national supply deals for months in anticipation of global demand for a winner. Even the lesser-known contestants are selling their wares around the world, though—and the U.K. appears to be buying. The biggest drugmakers in the hunt for a COVID-19 vaccine have been racing to lock up national supply deals for months in anticipation of global demand for a winner. Even the lesser-known contestants are selling their wares around the world, though—and the U.K. appears to be buying. 

Valneva signs $1.6B supply, development agreement with U.K. for coronavirus vaccine hopeful | FiercePharma

The suspension of a leading coronavirus vaccine trial had dashed investors' hopes of economic recovery worldwide, but the trial will now continue.The suspension of a leading coronavirus vaccine trial had dashed investors' hopes of economic recovery worldwide, but the trial will now continue.

Stocks rise as AstraZeneca resumes vaccine trial

Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won't happen unless people believe it's safe.Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won't happen unless people believe it's safe.

Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will

Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will

Bloomberg - Are you a robot?

AstraZeneca Plc’s Covid-19 vaccine trial remains on hold in the U.S. as regulators examine a serious side effect suffered by a U.K. patient, Reuters reported on Monday.

AstraZeneca trial on hold pending U.S. scrutiny, Reuters reports - BNN Bloomberg

'It will be very soon. The progress is currently very smooth,' said a Chinese official.'It will be very soon. The progress is currently very smooth,' said a Chinese official.

Coronavirus vaccine in China could be ready by November say officials - Business Insider

Open letter flags results that appear to be duplicated and calls for access to the underlying data on the first COVID-19 vaccine to be approved for widespread use. Open letter flags results that appear to be duplicated and calls for access to the underlying data on the first COVID-19 vaccine to be approved for widespread use.Open letter flags results that appear to be duplicated and calls for access to the underlying data on the first COVID-19 vaccine to be approved for widespread use.

Researchers highlight ‘questionable’ data in Russian coronavirus vaccine trial results

404 Not Found

Emergency use of the vaccine is fully and completely compatible with the regulations and laws that allow a faster review of licensing procedures - ZAWYA MENA EditionEmergency use of the vaccine is fully and completely compatible with the regulations and laws that allow a faster review of licensing procedures

Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, surmised that if we are able to bring a safe and effective vaccine to market by the end of 2020, it will still likely be late into 2021 before we are able to do once normal things, like going to a theater and comfortably not wearing a mask. Here’s everything else you need to know this week.Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, surmised that if we are able to bring a safe and effective vaccine to market by the end of 2020, it will still likely be late into 2021 before we are able to do once normal things, like going to a theater and comfortably not wearing a mask. Here’s everything else you need to know this week.

AstraZeneca resumed its COVID-19 vaccine trials after uncovering a mysterious reaction | Popular Science

A coronavirus vaccine currently being developed in China may be available to the general public as early as November in its phase 3 trial.Four COVID-19 vaccines are currently in the final stages of a clinical trial.

China’s Covid-19 vaccine may be ready for general public in November 2020

DUBAI: The UAE on Monday granted emergency approval for health workers to use a COVID-19 vaccine currently in its third phase of testing. Health minister Abdulrahman Al-Owais said the vaccine would be available for “first-line-of-defense heroes, who are most at risk of catching COVID-19, protecting them from any danger that they may be exposed to due to the nature of theirDUBAI: The UAE on Monday granted emergency approval for health workers to use a COVID-19 vaccine currently in its third phase of testing. Health minister Abdulrahman Al-Owais said the vaccine would

UAE approves COVID-19 vaccine for health workers | Arab News

403 Forbidden

A majority of Americans in the new NBC News|SurveyMonkey poll say they don't trust what President Donald Trump has said about a coronavirus vaccine. The share of people who say they would get a government-approved vaccine for Covid-19 has decreased in recent weeks in the NBC News|SurveyMonkey Weekly Tracking poll.

Poll: Majority of adults don't trust Trump's comments on Covid-19 vaccine

Coronavirus deaths pass 925,000; biosafety head at Chinese CDC says vaccine progress ‘very smooth’; South Korea to secure early vaccines for 30 millionCoronavirus deaths pass 925,000; biosafety head at Chinese CDC says vaccine progress ‘very smooth’; South Korea to secure early vaccines for 30 million

Global report: Covid cases near 30m as China expects vaccine as soon as November | Coronavirus outbreak | The Guardian

China has four COVID-19 vaccines in the final stage of clinical trials, at least three of those have already been offered to essential workersChina has four COVID-19 vaccines in the final stage of clinical trials, at least three of those have already been offered to essential workers

China COVID-19 vaccine may be ready for public in November, says official

In March, about 180 immunologists and epidemiologists with China National Pharmaceutical Industry Corp (SinoPharm), together with their families, signedIn March, about 180 immunologists and epidemiologists with China National Pharmaceutical Industry Corp (SinoPharm), together with their families, signed up to be the first volunteers to receive jab…

Debate rages over China's Covid-19 vaccines - Asia Times

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 14, 2020.Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 14, 2020.

Biopharma Update on the Novel Coronavirus: September 14 | BioSpace

Brazil's health regulator Anvisa on Tuesday authorized AstraZeneca PLC to test its COVID19 vaccine on an additional 5,000 volunteers in the country for clinical Phase III trials, the Sao Paulo university coordinating the test said.Brazil's health regulator Anvisa on Tuesday authorized AstraZeneca PLC to test its COVID19 vaccine on an additional 5,000 volunteers in the country for clinical Phase III trials, the Sao Paulo university coordinating the test said.

Brazil Authorizes Additional 5,000 Volunteers For AstraZeneca COVID-19 Vaccine

Oxford University said that trials of a COVID-19 vaccine it is developing with AstraZeneca would resume. From the vaccine, Hungary reserved 5 million doses.Oxford University said that trials of a COVID-19 vaccine it is developing with AstraZeneca would resume. From the vaccine, Hungary reserved 5 million doses.

Coronavirus: Oxford University to Continue Testing of Vaccine Hungary Reserved